Statehouse News: Ohio doctors recommend getting COVID-19 boosters now to protect against long-term damage
UC expert says some COVID-19 patients experience brain fog
The Ohio Department of Health recently announced COVID-19 boosters with the new formulation to target Omicron subvariants BA.4 and BA.5 are now available statewide.
The Pfizer booster is available to Ohioans 12-years-old and older and the Moderna vaccine is available to those 18 years and up. Statehouse News reported that doctors are urging Ohioans to get those vaccines now. One of those Ohio doctors is Anna Goroncy, MD, of the Department of Family and Community Medicine at the UC College of Medicine.
Statehouse News reported that while the newer variants of COVID-19 are less severe than previous ones, there is a growing concern about people who are developing "long COVID."
Anna Goroncy, MD, of the Department of Family and Community Medicine at the UC College of Medicine/Photo/Colleen Kelley/UC Marketing + Brand
Goroncy said some people are able to weather COVID-19 itself but are having neurological side effects like brain fog.
"We're basically creating a whole new group that may have long-term disabilities," she said. "We don’t know what that’s going to look like 10 years from now. Certainly, we are seeing the importance of inflammation around things like dementia and other brain disorders so it would make a lot of logical and physiological sense that we may see ongoing cognitive impairment or those people more at risk of cognitive impairment in the future.”
Ohio Department of Health Director Dr. Bruce Vanderhoff said the best defense against "long COVID" is getting boosted with the vaccine to prevent contracting the virus.
Vanderhoff said Ohioans might need to get an annual COVID-19 vaccine, just like some do with flu vaccines, in the future because the virus isn't going away any time soon.
Lead photo/Colleen Kelley/UC Marketing + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.